Research team
Expertise
I am a clinical epidemiologist with as main research interests the long-term effects of commonly prescribed drugs such as antibiotics and gastric-acid suppressors, potentially through interactions with the microbiome - with a focus on the gastro-intestinal and vaginal microbiome. My main clinical areas of expertise are cancer (in particular of the gastro-intestinal tract), women's health (incl. pregnancy) and infectious diseases. I am trained as a medical doctor, epidemiologist and infection control/hospital hygiene specialist but work as a full-time academic researcher.
The effect of antibiotics and proton pump inhibitors on the gut microbiome and infection risk in early life.
Abstract
Our gut microbiome is affected by many factors, and it seems (prescribed) drug use is one of the most important factors affecting its' composition and function. The first years of life are crucial for the acquisition of a healthy and stable gut microbiome, yet infancy is also when we use most antibiotics. Young infants may also receive gastric acid inhibitors for gastro-oesophageal reflux symptoms although efficacy and safety have been questioned. As antibiotics and gastric acid inhibitors are known to disrupt the gut microbiome in adults, these could even have larger and long-lasting effects on the microbiome and health of young children. With these projects, we want to contribute to mapping antibiotics and protonpump utilisation during early childhood – to assess the potential extent of overconsumption. We also want to explore drug-microbiome interactions in young children, and the potential bi-directional effect on infections. These projects might have direct clinical implications, by contributing to improved prescription practices and reducing inappropriate intake.Researcher(s)
- Promoter: Brusselaers Nele
- Co-promoter: Vlieghe Erika
- Fellow: Orwa Sheila
Research team(s)
Project type(s)
- Research Project
Laura project 2.0: Improving women's health in Peru with the support of higher education institutions, women and local authorities.
Abstract
Speaking openly about vaginal health is taboo in Peru, and public attention to intimate female care has been neglected for decades. For instance, during the present pandemic, several primary health care centers shut down gynaecological consultations, affecting women suffering from vaginal infections. With the current Laura 2.0 project, we aim to create a national (in Peru) and international research network investigating on vaginal health by actively engaging several key stakeholders from society and academia. Higher education institutions (HEIs) will play a key role in achieving Laura 2.0 aim. Universidad Nacional de la Amazonia Peruana (UNAP) and Universidad Nacional San Agustín de Arequipa (UNSA) are the prominent universities in the Peruvian Amazon and the Highlands regions, respectively. Both HEIs are strengthening their key roles in developing their regions by consolidating their research capacity. The current project will strengthen the national (UNAP-UNSA-UPCH) and international (local partners and UAntwerp) collaboration by actively developing research capacities in a multidisciplinary approach. More importantly involving (for the first time in Peru), citizens (women) in science, via a citizen science project inspired by the Belgian Isala project (https://isala.be/en).Researcher(s)
- Promoter: Lebeer Sarah
- Co-promoter: Brusselaers Nele
- Co-promoter: Condori Sandra
- Co-promoter: Verhoeven Veronique
Research team(s)
Project type(s)
- Research Project